These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

257 related items for PubMed ID: 3149743

  • 1. Neonatal 6-hydroxydopamine-induced dopamine depletions: motor activity and performance in maze learning.
    Archer T, Danysz W, Fredriksson A, Jonsson G, Luthman J, Sundström E, Teiling A.
    Pharmacol Biochem Behav; 1988 Oct; 31(2):357-64. PubMed ID: 3149743
    [Abstract] [Full Text] [Related]

  • 2. Functional changes induced by neonatal cerebral 6-hydroxydopamine treatment: effects of dose levels on behavioral parameters.
    Luthman J, Bassen M, Fredriksson A, Archer T.
    Behav Brain Res; 1997 Jan; 82(2):213-21. PubMed ID: 9030403
    [Abstract] [Full Text] [Related]

  • 3. Neonatal 6-hydroxydopamine attenuates the neural and behavioral effects of enriched rearing in the rat.
    O'Shea L, Saari M, Pappas BA, Ings R, Stange K.
    Eur J Pharmacol; 1983 Aug 19; 92(1-2):43-7. PubMed ID: 6414825
    [Abstract] [Full Text] [Related]

  • 4. Neonatal 6-hydroxydopamine lesions of the frontal cortex in rats: persisting effects on locomotor activity, learning and nicotine self-administration.
    Rezvani AH, Eddins D, Slade S, Hampton DS, Christopher NC, Petro A, Horton K, Johnson M, Levin ED.
    Neuroscience; 2008 Jun 26; 154(3):885-97. PubMed ID: 18511204
    [Abstract] [Full Text] [Related]

  • 5. [Spontaneous motor activity and radial-maze learning in rats neonatally treated with 6-hydroxydopamine].
    Iwasaki T, Takasuna M.
    Yakubutsu Seishin Kodo; 1986 Dec 26; 6(4):381-8. PubMed ID: 3103348
    [Abstract] [Full Text] [Related]

  • 6. Behavioral differences between neonatal and adult 6-hydroxydopamine-treated rats to dopamine agonists: relevance to neurological symptoms in clinical syndromes with reduced brain dopamine.
    Breese GR, Baumeister AA, McCown TJ, Emerick SG, Frye GD, Crotty K, Mueller RA.
    J Pharmacol Exp Ther; 1984 Nov 26; 231(2):343-54. PubMed ID: 6149306
    [Abstract] [Full Text] [Related]

  • 7. Functional changes implicating dopaminergic systems following perinatal treatments.
    Archer T, Fredriksson A.
    Dev Pharmacol Ther; 1992 Nov 26; 18(3-4):201-22. PubMed ID: 1306809
    [Abstract] [Full Text] [Related]

  • 8. Magnitude and duration of hyperactivity following neonatal 6-hydroxydopamine is related to the extent of brain dopamine depletion.
    Miller FE, Heffner TG, Kotake C, Seiden LS.
    Brain Res; 1981 Dec 14; 229(1):123-32. PubMed ID: 6796194
    [Abstract] [Full Text] [Related]

  • 9. Effects of bromocriptine in developing rat pups after 6-hydroxydopamine.
    Shaywitz BA, Lipton SV, Teicher MH, Cohen DJ, Anderson GM, Batter DK, Young JG.
    Pharmacol Biochem Behav; 1981 Sep 14; 15(3):443-8. PubMed ID: 6794039
    [Abstract] [Full Text] [Related]

  • 10. 6-OHDA induced effects upon the acquisition and performance of specific locomotor tasks in rats.
    Watson M, McElligott JG.
    Pharmacol Biochem Behav; 1983 Jun 14; 18(6):927-34. PubMed ID: 6412249
    [Abstract] [Full Text] [Related]

  • 11. Intraventricular 6-hydroxydopamine in the newborn rat and locomotor responses to drugs in infancy: no support for the dopamine depletion model of minimal brain dysfunction.
    Pappas BA, Gallivan JV, Dugas T, Saari M, Ings R.
    Psychopharmacology (Berl); 1980 Jun 14; 70(1):41-6. PubMed ID: 6775333
    [Abstract] [Full Text] [Related]

  • 12. Impaired acquisition of an operant response in young rats depleted of brain dopamine in neonatal life.
    Heffner TG, Seiden LS.
    Psychopharmacology (Berl); 1983 Jun 14; 79(2-3):115-9. PubMed ID: 6405418
    [Abstract] [Full Text] [Related]

  • 13. Enhancing effect of taurine in the rat caudate spindle. II. Effect of bilateral 6-hydroxydopamine lesions of the nigro-striatal dopamine system.
    Hashimoto-Kitsukawa S, Okuyama S, Aihara H.
    Pharmacol Biochem Behav; 1988 Oct 14; 31(2):417-23. PubMed ID: 3149745
    [Abstract] [Full Text] [Related]

  • 14. [Right/left discrimination learning in rat pups neonatally treated with 6-hydroxydopamine].
    Takasuna M, Iwasaki T.
    Yakubutsu Seishin Kodo; 1990 Jun 14; 10(2):315-21. PubMed ID: 2123587
    [Abstract] [Full Text] [Related]

  • 15. Behavioural supersensitivity following neonatal 6-hydroxydopamine: attenuation by MK-801.
    Archer T, Fredriksson A.
    Neurotox Res; 2007 Sep 14; 12(2):113-24. PubMed ID: 17967735
    [Abstract] [Full Text] [Related]

  • 16. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.
    Breese GR, Duncan GE, Napier TC, Bondy SC, Iorio LC, Mueller RA.
    J Pharmacol Exp Ther; 1987 Jan 14; 240(1):167-76. PubMed ID: 3100767
    [Abstract] [Full Text] [Related]

  • 17. Effects of adult or neonatal treatment with 6-hydroxydopamine or 5,7-dihydroxytryptamine on locomotor activity, monoamine levels, and response to caffeine.
    Erinoff L, Snodgrass SR.
    Pharmacol Biochem Behav; 1986 Apr 14; 24(4):1039-45. PubMed ID: 3086901
    [Abstract] [Full Text] [Related]

  • 18. Effects of d-amphetamine and apomorphine upon operant behavior and schedule-induced licking in rats with 6-hydroxydopamine-induced lesions of the nucleus accumbens.
    Robbins TW, Roberts DC, Koob GF.
    J Pharmacol Exp Ther; 1983 Mar 14; 224(3):662-73. PubMed ID: 6402587
    [Abstract] [Full Text] [Related]

  • 19. Behavioural retardation in the neuropathology of mental retardation.
    Archer T.
    APMIS Suppl; 1993 Mar 14; 40():35-56. PubMed ID: 7906129
    [Abstract] [Full Text] [Related]

  • 20. Effects of acute administration of DA agonists on locomotor activity: MPTP versus neonatal intracerebroventricular 6-OHDA treatment.
    Archer T, Palomo T, McArthur R, Fredriksson A.
    Neurotox Res; 2003 Mar 14; 5(1-2):95-110. PubMed ID: 12832225
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.